门诊起病急性下消化道出血早期与择期结肠镜随机对照试验方案
本研究为研究者发起的多中心随机开放标签平行组试验,比较门诊起病急性下消化道出血患者早期结肠镜(24小时内)与择期结肠镜(24至96小时)对近期出血征象识别率的影响,并评估30天再出血等临床结局,计划样本量可检测择期组9%与早期组≥26%的近期出血征象识别率差异(I类错误5%,把握度80%)。
要点
- 早期结肠镜定义为24小时内,择期结肠镜定义为24至96小时。
- 主要结局为近期出血征象识别率,假设早期结肠镜可提高识别率。
- 样本量基于择期组9%、早期组≥26%的识别率,检验水准5%,把握度80%。
核心结论
- 比较早期结肠镜与择期结肠镜对门诊起病急性下消化道出血患者近期出血征象识别率及30天再出血等临床结局的优劣。
研究设计与样本
- 研究者发起的多中心、随机、开放标签、平行组优效性试验,比较早期结肠镜与择期结肠镜在急性下消化道出血患者中的效果。
主要发现
- 主要结局为近期出血征象的识别;次要结局包括30天再出血、内镜治疗成功、需额外内镜检查、需介入放射学、需手术、住院期间输血、住院时长、30天血栓事件、30天死亡率、肠道准备相关不良事件及结肠镜相关不良事件。
关键数值与推荐
- 样本量设计可检测择期结肠镜组近期出血征象识别率9%与早期结肠镜组≥26%的差异,I类错误风险5%,把握度80%。
- 早期结肠镜定义为入院后24小时内进行,择期结肠镜定义为24至96小时内进行。
临床怎么用
- 为急性下消化道出血患者早期结肠镜的获益与风险提供高质量证据,辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical benefit of early colonoscopy within 24 h of arrival in patients with severe acute lower gastrointestinal bleeding (ALGIB) remains controversial. This trial will compare early colonoscopy (performed within 24 h) versus elective colonoscopy (performed between 24 and 96 h) to examine the identification rate of stigmata of recent hemorrhage (SRH) in ALGIB patients. We hypothesize that, compared with elective colonoscopy, early colonoscopy increases the identification of SRH and subsequently improves clinical outcomes. METHODS: This trial is an investigator-initiated, multicenter, randomized, open-label, parallel-group trial examining the superiority of early colonoscopy over elective colonoscopy (standard therapy) in ALGIB patients. The primary outcome measure is the identification of SRH. Secondary outcomes include 30-day rebleeding, success of endoscopic treatment, need for additional endoscopic examination, need for interventional radiology, need for surgery, need for transfusion during hospitalization, length of stay, 30-day thrombotic events, 30-day mortality, preparation-related adverse events, and colonoscopy-related adverse events. The sample size will enable detection of a 9% SRH rate in elective colonoscopy patients and a SRH rate of ≥ 26% in early colonoscopy patients with a risk of type I error of 5% and a power of 80%. DISCUSSION: This trial will provide high-quality data on the benefits and risks of early colonoscopy in ALGIB patients. TRIAL REGISTRATION: UMIN-CTR Identifier, UMIN000021129 . Registered on 21 February 2016; ClinicalTrials.gov Identifier, NCT03098173 . Registered on 24 March 2017.
引用
- Niikura R, Nagata N, Yamada A, et al. A multicenter, randomized controlled trial comparing the identification rate of stigmata of recent hemorrhage and rebleeding rate between early and elective colonoscopy in outpatient-onset acute lower gastrointestinal bleeding: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29615078. doi:10.1186/s13063-018-2558-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。